| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002016939A3 Methods of diagnosis of cancer and screening for cancer modulators |
| 01/23/2003 | WO2002012272A3 Therapeutic anti-melanoma compounds |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008293A3 Multivalent target binding protein |
| 01/23/2003 | WO2002008262A3 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/23/2003 | WO2001097843A3 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 01/23/2003 | WO2001090358A3 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | WO2001083782A3 Novel proteases |
| 01/23/2003 | WO2001063280A3 Inter-alpha-trypsin as a marker for sepsis |
| 01/23/2003 | US20030018183 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018174 Monoclonal antibodies to IFNAR2 |
| 01/23/2003 | US20030018173 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018172 Secreted transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018171 High affinity humanized anti-CEA monoclonal antibodies |
| 01/23/2003 | US20030018170 Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018006 Gene expression; plasmids; cancer therapy |
| 01/23/2003 | US20030018004 Vector |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017979 Antibody and chemokine constructs and their use in the treatment of infections and immunological diseases |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017584 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017534 Production of humanized antibodies in transgenic animals |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017517 Genes differentially expressed in breast cancer |
| 01/23/2003 | US20030017516 Detection of precancerous cells in mammals; obtain cell sample, incubate with antibody, bound anibody indicate precanceous cells |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017511 Nuclear myosin l beta with a 16 amino acid N-terminal extension |
| 01/23/2003 | US20030017504 Antibodies specific for poly(ethylene glycol) |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017488 Method for testing a therapeutic or preventive agent for hyperlipidemia |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017468 Nucleotide sequences which code lung preferential gene for use in the treatment and diagnosis of lung cancer |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017450 Detection of viral nucleotide sequences in sample; obtain sample, denature, incubate with pimers, hybridize, amplify, expose to probe, detect signal presence indicates viral nucleotide sequences |
| 01/23/2003 | US20030017448 Preventing uterine infection of fetuses; obtain swine, administer antibodies, monitor swine births for infected fetus, no infection indicates preventive antibody |
| 01/23/2003 | US20030017162 Preventing and treating Gram-negative sepsis. |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017159 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | US20030017155 Treating a condition characterized by activation of the inflammatory cytokine cascade |
| 01/23/2003 | US20030017154 Administering a gastrointestinal neuromodulator antibody. |
| 01/23/2003 | US20030017152 Administering a substance that specifically depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells, followed by transplantation with a donor cell preparation containing hematopoietic stem cells from a matched donor |
| 01/23/2003 | US20030017151 Receptor Activator of NF-kappa B antagonists; treatment of medical conditions that require the formation of new bone. |
| 01/23/2003 | US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/23/2003 | US20030017149 Screening a DNA construct library; diagnosing a physiological disorder manifested by an abnormal level of a transcription associated biomolecule. |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017141 Treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/23/2003 | CA2821544A1 Use of follistatin for the treatment of pulmonary fibrosis and fibrosis associated with inflammatory bowel disease |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453474A1 Vegfr-1 antibodies to treat breast cancer |
| 01/23/2003 | CA2453470A1 Use of follistatin for the treatment of hepatic fibrogenesis |
| 01/23/2003 | CA2453435A1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 01/23/2003 | CA2453403A1 Methods of inhibiting amyloid toxicity |
| 01/23/2003 | CA2452544A1 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2449243A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | CA2447585A1 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 01/22/2003 | EP1278065A1 Method of detecting streptococcus sobrinus and antibody therefor |
| 01/22/2003 | EP1277843A2 Novel human genes and gene expression products related to colon cancer |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277833A2 Costal-2 homologue |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276896A2 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276855A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276771A1 Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276757A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF |
| 01/22/2003 | EP1276557A2 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |